Advertisement

Topics

Finance Watch: Among Multiple Mega-Rounds, Revolution Raises $100m For RAS Programs

13:31 EDT 12 Jul 2019 | SCRIP

Private Company Edition: Revolution Medicines follows its Sanofi partnership and Warp Drive Bio buyout with a series C venture capital...

      

Related Stories

 

Original Article: Finance Watch: Among Multiple Mega-Rounds, Revolution Raises $100m For RAS Programs

NEXT ARTICLE

More From BioPortfolio on "Finance Watch: Among Multiple Mega-Rounds, Revolution Raises $100m For RAS Programs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...